LWMI
DNA icon

Legacy Wealth Management (Idaho)’s Ginkgo Bioworks DNA Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-112
Closed -$687 – 386
2026
Q1 		$687 Hold
112
– – ﹤0.01% 913
2025
Q4 		$931 Hold
112
– – ﹤0.01% 757
2025
Q3 		$1.63K Hold
112
– – ﹤0.01% 564
2025
Q2 		$1.26K Hold
112
– – ﹤0.01% 569
2025
Q1 		$639 Hold
112
– – ﹤0.01% 680
2024
Q4 		$1.6K Sell
112
-38
-25% -$326 ﹤0.01% 534
2024
Q3 		$1.29K Buy
+150
New +$1.5K ﹤0.01% 522

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Legacy Wealth Management (Idaho)'s DNA Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of Ginkgo Bioworks (DNA) in Q2 2026, closing a stake of 112 shares — an estimated $687 sold.

Legacy Wealth Management (Idaho) first reported a position in DNA in Q3 2024 and held it in 7 quarters. The position peaked at $1.63K in Q3 2025. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining Ginkgo Bioworks position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 112 Ginkgo Bioworks shares in Q2 2026, an estimated $687.
  • Legacy Wealth Management (Idaho) first reported a position in Ginkgo Bioworks in Q3 2024 and held it in 7 quarters.
  • Legacy Wealth Management (Idaho)'s Ginkgo Bioworks position peaked at $1.63K in Q3 2025.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.